Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2015. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to disclosure of insider trading activity.
Material Changes
No material financial changes versus prior periods are reported in this document. The only reported activity is a specific transaction involving a connected person.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly details a transfer of American Depositary Shares (ADSs).
Important Facts for Investors
- Transaction Type: Transfer of 1,301 ADSs from the GSK 401K plan to a personal account.
- Parties Involved: Dr. K. Slaoui (connected person of Director Dr. M. M. Slaoui).
- Transaction Date: May 21, 2015.
- Notification Date: The Company and the individual were advised of the transaction on May 22, 2015.
- Regulatory Basis: Filed in accordance with DTR 3.1.4 R(1)(c).